A Study Evaluating Effect of Tocilizumab on Long-Term Patient and Renal-Allograft Survival in Patients With Antibody-Mediated Rejection and Transplant Glomerulopathy.
Phase of Trial: Phase IV
Latest Information Update: 09 Nov 2016
At a glance
- Drugs Tocilizumab (Primary)
- Indications Kidney disorders; Renal transplant rejection
- Focus Therapeutic Use
- 09 Nov 2016 New trial record